Literature DB >> 20927589

Epigenetic silencing of somatostatin in gastric cancer.

Kaya Jackson1, Mohammed Soutto, DunFa Peng, TianLing Hu, Dana Marshal, Wael El-Rifai.   

Abstract

BACKGROUND: Somatostatin (SST), a primary inhibitor of gastrin-stimulated gastric acid secretion, has potent antitumor and anti-secretory activity in several human cancers. AIMS: This study was performed to investigate the SST gene expression levels and possible epigenetic mechanisms that regulate expression of SST in gastric adenocarcinomas.
METHODS: Quantitative real-time (RT)-PCR and quantitative bisulfite pyrosequencing were used to study primary gastric cancer tissue samples and cell lines.
RESULTS: Quantitative RT-PCR analysis revealed down-regulation of the SST transcript in 93% of gastric carcinoma samples (30/32), compared with 21 normal samples (P<0.001). Because of the presence of a large CpG island in the SST promoter, we next examined its promoter DNA methylation levels by use of quantitative bisulfite pyrosequencing. The results revealed a significant increase in SST promoter DNA methylation in tumor samples compared with normal samples (P<0.05). Promoter DNA hypermethylation and silencing of SST was also detected in seven gastric cancer cell lines that we tested. To confirm the role of promoter DNA methylation as an epigenetic mechanism regulating SST expression, AGS gastric cancer cells were treated with 5-Aza-dc. This treatment led to reduction of promoter DNA methylation levels of SST accompanied by restoration of its mRNA expression.
CONCLUSIONS: Our results indicate that promoter DNA methylation levels play a critical role in regulating SST expression in gastric cancer. This finding provides a foundation for further studies on the role of SST in gastric carcinogenesis and its potential as a biomarker for gastric cancers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20927589      PMCID: PMC3082506          DOI: 10.1007/s10620-010-1422-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  24 in total

1.  Gastric cancers overexpress S100A calcium-binding proteins.

Authors:  Wa'el El-Rifai; Christopher A Moskaluk; Mohammad Khalouck Abdrabbo; Jeffery Harper; Cynthia Yoshida; Gregory J Riggins; Henry F Frierson; Steven M Powell
Journal:  Cancer Res       Date:  2002-12-01       Impact factor: 12.701

2.  Promoter DNA hypermethylation in gastric biopsies from subjects at high and low risk for gastric cancer.

Authors:  Barbara G Schneider; Dun-Fa Peng; M Constanza Camargo; M Blanca Piazuelo; Liviu A Sicinschi; Robertino Mera; Judith Romero-Gallo; Alberto G Delgado; Luis E Bravo; Keith T Wilson; Richard M Peek; Pelayo Correa; Wael El-Rifai
Journal:  Int J Cancer       Date:  2010-12-01       Impact factor: 7.396

3.  Epigenetic silencing of genes in human colon cancer.

Authors:  Rodger A Liddle; Randy L Jirtle
Journal:  Gastroenterology       Date:  2006-09       Impact factor: 22.682

4.  Histone deacetylase inhibitor Trichostatin A induces global and gene-specific DNA demethylation in human cancer cell lines.

Authors:  Jing-Ni Ou; Jérôme Torrisani; Alexander Unterberger; Nadine Provençal; Keisuke Shikimi; Mohsen Karimi; Tomas J Ekström; Moshe Szyf
Journal:  Biochem Pharmacol       Date:  2007-01-05       Impact factor: 5.858

5.  A genome-wide search identifies epigenetic silencing of somatostatin, tachykinin-1, and 5 other genes in colon cancer.

Authors:  Yuriko Mori; Kun Cai; Yulan Cheng; Suna Wang; Bogdan Paun; James P Hamilton; Zhe Jin; Fumiaki Sato; Agnes T Berki; Takatsugu Kan; Tetsuo Ito; Carmit Mantzur; John M Abraham; Stephen J Meltzer
Journal:  Gastroenterology       Date:  2006-09       Impact factor: 22.682

6.  Hypermethylation of the somatostatin promoter is a common, early event in human esophageal carcinogenesis.

Authors:  Zhe Jin; Yuriko Mori; James P Hamilton; Alexandru Olaru; Fumiaki Sato; Jian Yang; Tetsuo Ito; Takatsugu Kan; Rachana Agarwal; Stephen J Meltzer
Journal:  Cancer       Date:  2008-01-01       Impact factor: 6.860

7.  DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett's adenocarcinoma.

Authors:  D F Peng; M Razvi; H Chen; K Washington; A Roessner; R Schneider-Stock; W El-Rifai
Journal:  Gut       Date:  2008-07-29       Impact factor: 23.059

Review 8.  Epidemiology of gastric cancer.

Authors:  Katherine D Crew; Alfred I Neugut
Journal:  World J Gastroenterol       Date:  2006-01-21       Impact factor: 5.742

Review 9.  Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction?

Authors:  Stephen B Baylin; Joyce E Ohm
Journal:  Nat Rev Cancer       Date:  2006-02       Impact factor: 60.716

10.  Histone deacetylase inhibitor depsipeptide activates silenced genes through decreasing both CpG and H3K9 methylation on the promoter.

Authors:  Li-Peng Wu; Xi Wang; Lian Li; Ying Zhao; Shaoli Lu; Yu Yu; Wen Zhou; Xiangyu Liu; Jing Yang; Zhixin Zheng; Hui Zhang; Jingnan Feng; Yang Yang; Haiying Wang; Wei-Guo Zhu
Journal:  Mol Cell Biol       Date:  2008-03-10       Impact factor: 4.272

View more
  21 in total

1.  Somatostatin methylation as a biomarker for gastric cancer: ready for "prime time" or for further validation?

Authors:  Ajay Goel
Journal:  Dig Dis Sci       Date:  2011-01       Impact factor: 3.199

2.  GABAergic control of depression-related brain states.

Authors:  Bernhard Luscher; Thomas Fuchs
Journal:  Adv Pharmacol       Date:  2015-01-14

3.  Epigenetic control of cancer by neuropeptides.

Authors:  Karina Galoian; Parthik Patel
Journal:  Biomed Rep       Date:  2016-11-08

4.  A high-fat diet regulates gastrin and acid secretion through primary cilia.

Authors:  Milena Saqui-Salces; William E Dowdle; Jeremy F Reiter; Juanita L Merchant
Journal:  FASEB J       Date:  2012-04-18       Impact factor: 5.191

5.  Methylation of serum SST gene is an independent prognostic marker in colorectal cancer.

Authors:  Yanqun Liu; Min Hoe Chew; Chee Kian Tham; Choong Leong Tang; Simon Yk Ong; Yi Zhao
Journal:  Am J Cancer Res       Date:  2016-09-01       Impact factor: 6.166

Review 6.  Epigenetic therapy in gastrointestinal cancer: the right combination.

Authors:  Eihab Abdelfatah; Zachary Kerner; Nainika Nanda; Nita Ahuja
Journal:  Therap Adv Gastroenterol       Date:  2016-05-01       Impact factor: 4.409

7.  Genome-wide CpG island methylation analysis implicates novel genes in the pathogenesis of renal cell carcinoma.

Authors:  Christopher J Ricketts; Mark R Morris; Dean Gentle; Michael Brown; Naomi Wake; Emma R Woodward; Noel Clarke; Farida Latif; Eamonn R Maher
Journal:  Epigenetics       Date:  2012-03       Impact factor: 4.528

8.  Age-related DNA methylation in paired normal and tumour breast tissue in Chinese breast cancer patients.

Authors:  Maeve Kiely; Lap Ah Tse; Hela Koka; Difei Wang; Priscilla Lee; Feng Wang; Cherry Wu; Koon Ho Tsang; Wing-Cheong Chan; Sze Hong Law; Han Zhang; Eric Karlins; Bin Zhu; Amy Hutchinson; Belynda Hicks; Bin Zhu; Xiaohong R Yang
Journal:  Epigenetics       Date:  2020-09-24       Impact factor: 4.528

9.  Aberrant promoter methylation and expression of UTF1 during cervical carcinogenesis.

Authors:  Samuel Guenin; Mustapha Mouallif; Rachel Deplus; Xavier Lampe; Nathalie Krusy; Emilie Calonne; Katty Delbecque; Frederic Kridelka; François Fuks; My Mustapha Ennaji; Philippe Delvenne
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

10.  Peptide receptor targeting in cancer: the somatostatin paradigm.

Authors:  Federica Barbieri; Adriana Bajetto; Alessandra Pattarozzi; Monica Gatti; Roberto Würth; Stefano Thellung; Alessandro Corsaro; Valentina Villa; Mario Nizzari; Tullio Florio
Journal:  Int J Pept       Date:  2013-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.